Evolution of asthma during pregnancy: Difference based on the sex of the newborn

E. Martinez Moragon, T. Bazus, B. Antequera, A. Romero, A. Rosado, C. Martinez Rivera, J. L. Garcia R., F. Albiñana, A. de Diego, R. Costa (Valencia, Oviedo, Port Sagunt, Sevilla, Madrid, Barcelona, Cantabria, Spain)

Source: Annual Congress 2013 –Diagnosis and management of respiratory diseases
Session: Diagnosis and management of respiratory diseases
Session type: Thematic Poster Session
Number: 4161
Disease area: Airway diseases

Congress or journal article abstractE-poster

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
E. Martinez Moragon, T. Bazus, B. Antequera, A. Romero, A. Rosado, C. Martinez Rivera, J. L. Garcia R., F. Albiñana, A. de Diego, R. Costa (Valencia, Oviedo, Port Sagunt, Sevilla, Madrid, Barcelona, Cantabria, Spain). Evolution of asthma during pregnancy: Difference based on the sex of the newborn. Eur Respir J 2013; 42: Suppl. 57, 4161

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Informativity of biometric and functional parameters for asthma control verification in children
Source: International Congress 2016 – Techniques and tools in paediatric asthma
Year: 2016

Prevalence and relationship of hypomagnesiemia with children bronchial asthma control
Source: International Congress 2016 – Paediatric asthma: lessons learned from studies with large sample sizes and multi-centre drug studies
Year: 2016


The difference of FENO levels according to gender in healty subjects never smoked
Source: International Congress 2014 – Airway biomarkers
Year: 2014

Interaction between airway calibre and exhaled NO: Impact on asthma control assessment
Source: Annual Congress 2013 –Diagnosis and management of respiratory diseases
Year: 2013

Meta-analysis of the accuracy of screening adult asthma using exhaled nitric oxide
Source: Annual Congress 2013 –Studies of asthma in man
Year: 2013


Further evidence that FeNO directed therapy reduces asthma exacerbations
Source: International Congress 2014 – Airway biomarkers
Year: 2014


Inflammatory patterns in asthmatic children based on the measurement of alveolar nitric oxide
Source: Annual Congress 2013 –Monitoring asthma: genes, cells and molecules
Year: 2013


Validation of ATS cut-off points for FeNO in a clinical unselected population of subjects with possible asthma
Source: International Congress 2014 – Systemic and airway biomarkers
Year: 2014

Positive relationship between offline exhaled nitric oxide and lung clearance index in pre-school wheezers
Source: International Congress 2014 – Paediatric asthma: lung function testing and more
Year: 2014

The role of FeNO measurement in exploration of respiratory symptoms in children with no diagnosis of asthma
Source: International Congress 2015 – Paediatric epidemiology: pulmonary complications, bronchiolitis and asthma
Year: 2015


Exhaled nitric oxide and the therapeutic regimens in childhood asthma
Source: Annual Congress 2013 –Monitoring asthma: genes, cells and molecules
Year: 2013

Alveolar nitric oxide and its role in asthma control assessment
Source: Annual Congress 2013 –Monitoring asthma: genes, cells and molecules
Year: 2013


Late Breaking Abstract - Management of asthma in pregnancy using fractional exhaled nitric oxide (FENO) to adjust inhaled corticosteroid (ICS) dose did not improve perinatal outcomes: the Breathing for Life Trial (BLT)
Source: Virtual Congress 2020 – Lung function tests and exhaled biomarkers
Year: 2020


Cost savings using fractional exhaled nitric oxide (FeNO) testing in asthma management by specialists
Source: Annual Congress 2013 –Assessment of airway inflammation by exhaled gases
Year: 2013


Economic evaluation of fractional exhaled nitric oxide (FENO) for the management of adult asthma in Spain
Source: International Congress 2015 – Exhaled biomarkers in children and adults with airways disease
Year: 2015

Small airway dysfunction and its role in pediatric asthma control assessment
Source: International Congress 2016 – Techniques and tools in paediatric asthma
Year: 2016


The experience of monitoring the exhaled nitric oxide (FeNO) during the anti-IgE-therapy (omalizumab) in children with uncontrolled severe asthma
Source: International Congress 2015 – Exhaled biomarkers in monitoring airways disease
Year: 2015


Exhaled nitric oxide and the risk of wheezing in infancy: the Generation R Study
Source: Eur Respir J 2012; 39: 567-572
Year: 2012



Associations between fractional exhaled nitric oxide (FeNO), asthma, respiratory symptoms and self-reported allergies in female university students in Kobe, Japan
Source: International Congress 2015 – Risk factors and co-morbidities in asthma and COPD
Year: 2015

Relationships between exhaled nitric oxide and atopic profiles (mono-sensitization/poly-sensitization) in asthmatic patients
Source: Annual Congress 2013 –Treatment of asthma
Year: 2013